Home/Filings/4/0001104659-23-003863
4//SEC Filing

Shemesh Shay 4

Accession 0001104659-23-003863

CIK 0001875558other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 5:04 PM ET

Size

4.8 KB

Accession

0001104659-23-003863

Insider Transaction Report

Form 4
Period: 2023-01-12
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
  • Award

    Common Stock

    2023-01-12+115,0001,360,865 total
Footnotes (2)
  • [F1]The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026.
  • [F2]Includes 48,399 shares of restricted stock and 175,000 restricted stock units.

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1
  • filerCIK 0001896056

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:04 PM ET
Size
4.8 KB